Preface to the Fourth Edition
To view all the Guidelines in PDF form, click this link.
Spina Bifida is the most commonly-occurring complex congenital birth defect associated with long-term survival. With this understanding, along with the knowledge of the multiple medical and psychosocial issues that people with Spina Bifida face, the Guidelines for Spina Bifida Health Care Services Throughout the Lifespan were first published by the Spina Bifida Association of America (now known as the Spina Bifida Association, SBA) in 1990 and revised in 1995. Both editions were the culmination of several years of work by SBA’s Professional Advisory Council (PAC), as well as numerous consultants under the editorial leadership of Karen Rauen, RN, MSN. These guidelines were based on limited contemporary knowledge and expert opinion.
Research on outcomes in Spina Bifida has been sparse. In that light, a symposium entitled: Evidence-Based Practice in Spina Bifida: Defining a Research Agenda was convened May 9-10, 2003 to identify the current evidence related to Spina Bifida, identify research gaps and priorities, and to foster new directions and funding for research. Sponsors included the Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, the National Institutes of Health (Office of Rare Diseases), and the U. S. Department of Education. Additional supporting agencies included the National Institute of Child Health and Human Development, the Interagency Committee on Disability Research, and the Spina Bifida Association. (A summary manuscript, edited by Gregory Liptak, MD, MPH, is available from the Spina Bifida Association, 1600 Wilson Blvd, Suite 800, Arlington, VA 22209.)
This meeting highlighted that much of the research in Spina Bifida was based on case series; very few randomized control trials or representative cohort studies had been performed on any topic on people with Spina Bifida. Research related to adults with Spina Bifida was nearly nonexistent. The primary goal of the evidence-based review was achieved: directions for research were clarified. The third edition of the Guidelines for Spina Bifida Health Care Services Throughout the Lifespan, edited by Mark Merkens, MD, was published in 2006 by SBA. The guidance included in the third edition was based on reviews generated from the evidence-based conference as well as expert consensus.
Guidelines for the Care of People with Spina Bifida are the fourth edition of the Guidelines, and the result of three years of planning, literature review and content development by nearly 100 volunteers. The new Guidelines were needed to ensure that all people living with Spina Bifida receive the best and most up-to-date care possible and because previous versions did not have robust coverage of the care needs of adults. Additionally, the fourth version features a new title that reflects greater respect and understanding for the people who are impacted by living with Spina Bifida. In other words, the fourth edition Guidelines were developed to treat and care for the people who live with Spina Bifida, not just the conditions associated with this birth defect. Finally, this fourth edition features a number of new topics, including Transition and Quality of Life, important to the health and well-being for all people living with Spina Bifida.
Despite the efforts resulting from the “Evidence-Based Practice in Spina Bifida: Developing a Research Agenda” conference in 2003, the extensive literature review done for the fourth edition of the Guidelines continues to identify that research in Spina Bifida remains limited. Where evidence exists, it is included. For other recommendations, the collective judgment of expert working groups determined the appropriateness of assessments and interventions to be considered. The workgroups used the consensus-building methodologies of Single Text Procedure and Nominal Group Techniques. These recognized guidelines development methodologies allow the inclusion of expert opinion for aspects of care for which medical evidence does not exist or is not robust.
Since the publication of the third edition of the Guidelines, there have been advances in health care service delivery concepts related to improving the care of children with a medical complexity, including Spina Bifida. These concepts will be important in ensuring the full implementation of the fourth edition of the Guidelines for the Care of People with Spina Bifida.
The first is that care coordination is an essential component of health care delivery. At the core, patient- and family-centered care within a medical home is a foundational component; outcomes are optimized when there is cross-sector collaboration among the multiple medical systems and providers, community services, and support agencies with whom families and people with Spina Bifida interact. While effective care coordination typically requires dedicated paid personnel, care coordination activities are not the sole responsibility of a single individual or provider. Rather, all people who interact with patients and families have a role to play in care coordination.
The second concept, in the context of patient- and family-centered care, is that for people with Spina Bifida, care providers may be provided via a medical neighborhood with team-based care. Within this framework is co-management with defined roles, data sharing, and collaborative care protocols among primary care, community-based services, and subspecialty care. Full implementation of these Guidelines to optimize outcomes for people with Spina Bifida cannot rest with the Spina Bifida clinic alone. Indeed, guidance provided on many topics should be implemented through primary care providers and efforts of community services. While the Spina Bifida clinic may direct the overall health care planning in many cases, optimal care is best achieved as a partnership between families and people with Spina Bifida, primary and subspecialty care providers, health systems, and community services.
These Guidelines were developed to serve people with Spina Bifida and those who care for them. It is essential to remember that several factors influence how an individual or family member uses the education and written information they are provided. This is imperative, particularly when reaching across potential obstacles such as cultural and/or language differences. It is known that the dynamics that modify the incidence of Spina Bifida are multifactorial, such as the well-documented higher incidence of Spina Bifida among people of Hispanic origin. Thus, it is increasingly critical for health care and community service providers to consider how a family’s language, level of acculturation, and cultural constructs of care (e.g. the concept of self-management and independence from others) directly influence their understanding and reception of the health care message along with their willingness to change behavior.10 Moreover, since over 20% of the US population older than five years of age speaks a language other than English at home, when possible, all families with limited English proficiency ought to be supported with additional health care navigation services, along with oral and written information provided in their preferred language.11
- Timothy J. Brei, MD, Spina Bifida Association Medical Director; Developmental Pediatrician, Professor, Seattle Children’s Hospital
- Sara Struwe, MPA, Spina Bifida Association President & Chief Executive Officer
- Patricia Beierwaltes, DPN, CPNP, Guideline Steering Committee Co-Chair; Assistant Professor, Nursing, Minnesota State University, Mankato
- Brad E. Dicianno, MD, Guideline Steering Committee Co-Chair; Associate Medical Director and Chair of Spina Bifida Association’s Professional Advisory Council; Associate Professor, Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine
- Nienke Dosa MD, MPH, Guideline Steering Committee Co-Chair; Upstate Foundation Professor of Child Health Policy; SUNY Upstate Medical University
- Lisa Raman, RN, MScANP, MEd, former Spina Bifida Association Director, Patient and Clinical Services
- Jerome B. Chelliah, MD, MPH, Johns Hopkins Bloomberg School of Public Health
- Julie Bolen, PhD, MPH, Lead Health Scientist, Rare Disorders Health Outcomes Team, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention
- Adrienne Herron, PhD Behavioral Scientist, Intervention Research Team, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
- Judy Thibadeau, RN, MN, Spina Bifida Association Director, Research and Services; former Health Scientist, National Spina Bifida Program, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention
The development of these Guidelines was supported in part by Cooperative Agreement UO1DD001077, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Centers for Disease Control and Prevention or the Department of Health and Human Services.